Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Suzhou Academy of Wumen Chinese Medicine, Suzhou Hospital of Traditional Chinese Medicine, Suzhou, China.
J Leukoc Biol. 2020 Jul;108(1):59-71. doi: 10.1002/JLB.3HI0220-342RR. Epub 2020 Apr 17.
Allergic asthma is a common chronic lung inflammatory disease and seriously influences public health. We aim to investigate the effects of formononetin (FMN) and calycosin (CAL), 2 flavonoids in Radix Astragali, on allergic asthma and elucidate possible therapeutic targets. A house dust mite (HDM)-induced allergic asthma mouse model and TNF-α and Poly(I:C) co-stimulated human bronchial epithelial cell line (16HBE) were performed respectively in vivo and in vitro. The role of G protein-coupled estrogen receptor (GPER) was explored by its agonist, antagonist, or GPER small interfering RNA (siGPER). E-cadherin, occludin, and GPER were detected by western blotting, immunohistochemistry, or immunofluorescence. The epithelial barrier integrity was assessed by trans-epithelial electric resistance (TEER). Cytokines were examined by enzyme-linked immunosorbent assay (ELISA). The results showed that flavonoids attenuated pulmonary inflammation and hyperresponsiveness in asthmatic mice. These flavonoids significantly inhibited thymic stromal lymphopoietin (TSLP), increased occludin and restored E-cadherin in vivo and in vitro. The effects of flavonoids on occludin and TSLP were not interfered by ICI182780 (estrogen receptor antagonist), while blocked by G15 (GPER antagonist). Furthermore, compared with PPT (ERα agonist) and DPN (ERβ agonist), G1 (GPER agonist) significantly inhibited TSLP, up-regulated occludin, and restored E-cadherin. siGPER and TEER assays suggested that GPER was pivotal for the flavonoids on the epithelial barrier integrity. Finally, G1 attenuated allergic lung inflammation, which could be abolished by G15. Our data demonstrated that 2 flavonoids in Radix Astragali could alleviate allergic asthma by protecting epithelial integrity via regulating GPER, and activating GPER might be a possible therapeutic strategy against allergic inflammation.
变应性哮喘是一种常见的慢性肺部炎症性疾病,严重影响公众健康。我们旨在研究黄芪中的两种黄酮类化合物芒柄花素(FMN)和毛蕊异黄酮(CAL)对变应性哮喘的影响,并阐明可能的治疗靶点。分别在体内和体外使用屋尘螨(HDM)诱导的变应性哮喘小鼠模型和 TNF-α和 Poly(I:C) 共刺激的人支气管上皮细胞系(16HBE)进行实验。通过其激动剂、拮抗剂或 GPER 小干扰 RNA(siGPER)来研究 G 蛋白偶联雌激素受体(GPER)的作用。通过 Western blot、免疫组织化学或免疫荧光法检测 E-钙黏蛋白、闭合蛋白和 GPER。通过跨上皮电阻(TEER)评估上皮屏障完整性。通过酶联免疫吸附试验(ELISA)检测细胞因子。结果表明,黄酮类化合物可减轻哮喘小鼠的肺部炎症和高反应性。这些黄酮类化合物可显著抑制胸腺基质淋巴细胞生成素(TSLP),增加闭合蛋白,并在体内和体外恢复 E-钙黏蛋白。黄酮类化合物对闭合蛋白和 TSLP 的作用不受 ICI182780(雌激素受体拮抗剂)的干扰,但被 G15(GPER 拮抗剂)阻断。此外,与 PPT(ERα激动剂)和 DPN(ERβ激动剂)相比,G1(GPER 激动剂)可显著抑制 TSLP,上调闭合蛋白,并恢复 E-钙黏蛋白。siGPER 和 TEER 测定表明,GPER 对黄酮类化合物维持上皮屏障完整性至关重要。最后,G1 可减轻过敏引起的肺部炎症,而 G15 可消除这种作用。我们的数据表明,黄芪中的 2 种黄酮类化合物可通过调节 GPER 来保护上皮完整性来缓解变应性哮喘,激活 GPER 可能是治疗变应性炎症的一种可行策略。